Eglė Puncevičienė, Justina Gaiževska, Rasa Sabaliauskaitė, Kristina Šnipaitienė, Lina Vencevičienė, Dalius Vitkus, Sonata Jarmalaitė, Irena Butrimienė
{"title":"Analysis of Epigenetic Changes in Vitamin D Pathway Genes in Rheumatoid Arthritis Patients.","authors":"Eglė Puncevičienė, Justina Gaiževska, Rasa Sabaliauskaitė, Kristina Šnipaitienė, Lina Vencevičienė, Dalius Vitkus, Sonata Jarmalaitė, Irena Butrimienė","doi":"10.15388/Amed.2021.29.1.7","DOIUrl":null,"url":null,"abstract":"<p><strong>Background: </strong>Rheumatoid arthritis (RA) is an autoimmune inflammatory disease with complex etiopathogenesis launched by multiple risk factors, including epigenetic alterations. RA is possibly linked to vitamin D that is epigenetically active and may alter DNA methylation of certain genes. Therefore, the study aimed to evaluate the relationship between DNA methylation status of vitamin D signaling pathway genes (<i>VDR, CYP24A1, CYP2R1</i>), vitamin D level and associations with RA.</p><p><strong>Materials and methods: </strong>Totally 76 participants (35 RA patients and 41 healthy controls) were enrolled from a case-control vitamin D and <i>VDR</i> gene polymorphisms study regarding age and vitamin D concentration. CpG islands in promoter regions of the <i>VDR, CYP24A1, CYP2R1</i> genes were chosen for DNA methylation analysis by means of pyrosequencing. Chemiluminescent microplate immunoassay was used to assess 25(OH)D serum levels. RA clinical data, i.e. the disease activity score C-reactive protein 28 (DAS28 - CRP) as well as patient-reported outcome questionnaires were recorded.</p><p><strong>Results: </strong>The study showed similar methylation pattern in the promoter regions of vitamin D pathway genes in RA and control group with <i>p</i>>0.05 (<i>VDR</i> gene 2.39% <i>vs.</i> 2.48%, <i>CYP24A1</i> gene 16.02% <i>vs.</i> 15.17% and <i>CYP2R1</i> 2.53% <i>vs.</i> 2.41%). <i>CYP24A1</i> methylation intensity was significantly higher in compare to methylation intensity of <i>VDR</i> and <i>CYP2R1</i> genes in both groups (<i>p</i><0.0001). A tendency of higher vitamin D concentration in cases having methylated <i>VDR (</i>57.57±28.93 <i>vs.</i> 47.40±29.88 nmol/l), <i>CYP24A1 (</i>53.23±26.22 <i>vs.</i> 48.23±34.41 nmol/l) and <i>CYP2R1</i> (60.41±30.73 <i>vs.</i> 44.54±27.63 nmol/l) genes and a positive correlation between <i>VDR, CYP2R1</i> methylation intensity and vitamin D level in RA affected participants was revealed (<i>p</i>>0.05). A significantly higher <i>CYP24A1</i> methylation intensity (<i>p</i>=0.0104) was detected in blood cells of vitamin D deficient (<50 nmol/l) RA patients <i>vs.</i> vitamin D deficient controls.</p><p><strong>Conclusions: </strong>Our data suggests some indirect associations between DNA methylation status of vitamin D pathway genes and vitamin D level in RA.</p>","PeriodicalId":34365,"journal":{"name":"Acta Medica Lituanica","volume":"29 1","pages":"78-90"},"PeriodicalIF":0.0000,"publicationDate":"2022-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9428646/pdf/","citationCount":"1","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Acta Medica Lituanica","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.15388/Amed.2021.29.1.7","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2022/7/26 0:00:00","PubModel":"Epub","JCR":"Q3","JCRName":"Medicine","Score":null,"Total":0}
引用次数: 1
Abstract
Background: Rheumatoid arthritis (RA) is an autoimmune inflammatory disease with complex etiopathogenesis launched by multiple risk factors, including epigenetic alterations. RA is possibly linked to vitamin D that is epigenetically active and may alter DNA methylation of certain genes. Therefore, the study aimed to evaluate the relationship between DNA methylation status of vitamin D signaling pathway genes (VDR, CYP24A1, CYP2R1), vitamin D level and associations with RA.
Materials and methods: Totally 76 participants (35 RA patients and 41 healthy controls) were enrolled from a case-control vitamin D and VDR gene polymorphisms study regarding age and vitamin D concentration. CpG islands in promoter regions of the VDR, CYP24A1, CYP2R1 genes were chosen for DNA methylation analysis by means of pyrosequencing. Chemiluminescent microplate immunoassay was used to assess 25(OH)D serum levels. RA clinical data, i.e. the disease activity score C-reactive protein 28 (DAS28 - CRP) as well as patient-reported outcome questionnaires were recorded.
Results: The study showed similar methylation pattern in the promoter regions of vitamin D pathway genes in RA and control group with p>0.05 (VDR gene 2.39% vs. 2.48%, CYP24A1 gene 16.02% vs. 15.17% and CYP2R1 2.53% vs. 2.41%). CYP24A1 methylation intensity was significantly higher in compare to methylation intensity of VDR and CYP2R1 genes in both groups (p<0.0001). A tendency of higher vitamin D concentration in cases having methylated VDR (57.57±28.93 vs. 47.40±29.88 nmol/l), CYP24A1 (53.23±26.22 vs. 48.23±34.41 nmol/l) and CYP2R1 (60.41±30.73 vs. 44.54±27.63 nmol/l) genes and a positive correlation between VDR, CYP2R1 methylation intensity and vitamin D level in RA affected participants was revealed (p>0.05). A significantly higher CYP24A1 methylation intensity (p=0.0104) was detected in blood cells of vitamin D deficient (<50 nmol/l) RA patients vs. vitamin D deficient controls.
Conclusions: Our data suggests some indirect associations between DNA methylation status of vitamin D pathway genes and vitamin D level in RA.
背景:类风湿性关节炎(RA)是一种自身免疫性炎症性疾病,其发病机制复杂,由多种危险因素引发,包括表观遗传改变。类风湿性关节炎可能与维生素D有关,维生素D具有表观遗传活性,可能会改变某些基因的DNA甲基化。因此,本研究旨在评估维生素D信号通路基因(VDR、CYP24A1、CYP2R1)的DNA甲基化状态与维生素D水平及其与RA的相关性。材料和方法:76名参与者(35名RA患者和41名健康对照)参与了一项与年龄和维生素D浓度相关的维生素D和VDR基因多态性研究。选择VDR、CYP24A1、CYP2R1基因启动子区域的CpG岛,通过焦磷酸测序进行DNA甲基化分析。化学发光微孔板免疫分析法检测血清25(OH)D水平。记录RA临床数据,即疾病活动性评分c -反应蛋白28 (DAS28 - CRP)以及患者报告的结局问卷。结果:RA组维生素D通路基因启动子区甲基化模式与对照组相似,p>0.05 (VDR基因2.39%比2.48%,CYP24A1基因16.02%比15.17%,CYP2R1基因2.53%比2.41%)。CYP24A1甲基化强度显著高于两组VDR和CYP2R1基因的甲基化强度(pVDR(57.57±28.93 vs. 47.40±29.88 nmol/l)、CYP24A1(53.23±26.22 vs. 48.23±34.41 nmol/l)和CYP2R1(60.41±30.73 vs. 44.54±27.63 nmol/l),发现RA患者VDR、CYP2R1甲基化强度与维生素D水平呈正相关(p>0.05)。与缺乏维生素D的对照组相比,在维生素D缺乏的血细胞中检测到明显更高的CYP24A1甲基化强度(p=0.0104)。结论:我们的数据提示RA中维生素D通路基因的DNA甲基化状态与维生素D水平之间存在一些间接关联。